Hepatitis C was once a chronic, often disabling condition with no reliable treatment. Today, direct-acting antiviral (DAA) medications cure most cases in 8–12 weeks with a success rate above 95%. That medical reality raises a pressing question for anyone receiving — or applying for — SSDI: does a cure change your eligibility?
The answer is not a simple yes or no. It depends on timing, lingering damage, your work history, and how the SSA evaluates your specific medical record.
SSDI is not a diagnosis-based program. The Social Security Administration doesn't approve or deny claims based on a condition's name — it evaluates functional limitations: what you can and cannot do, for how long, and whether any employer would reasonably hire you given those limitations.
For hepatitis C, the SSA looks at:
The SSA uses a framework called the Residual Functional Capacity (RFC) assessment — an evaluation of what work-related activities you can still perform despite your condition. A claimant with advanced cirrhosis and hepatic encephalopathy will have a very different RFC than someone with mild fibrosis.
Achieving sustained virologic response (SVR) — meaning the hepatitis C virus is undetectable 12 weeks after completing treatment — is the standard definition of a cure. The virus is gone.
But "cured" and "fully recovered" are not the same thing.
Hepatitis C can cause permanent liver damage that persists long after the virus is eliminated. This includes:
For a claimant whose limitations stem from the virus itself rather than permanent structural damage, the SSA may determine that the disabling condition has improved — and benefits could be reconsidered. For someone with irreversible cirrhosis, a cure of the underlying infection doesn't erase the disability.
Once approved for SSDI, recipients are subject to periodic Continuing Disability Reviews (CDRs). These reviews assess whether a recipient's condition has improved enough that they can return to substantial work.
If hepatitis C was the primary basis for your SSDI approval, and you are subsequently cured, the SSA may initiate a CDR triggered by the medical improvement. The review will focus on:
| Factor | What SSA Examines |
|---|---|
| Virus status | Is SVR confirmed? |
| Liver damage | Cirrhosis stage, current lab values |
| Functional capacity | Updated RFC assessment |
| Ongoing symptoms | Fatigue, cognitive function, pain |
| Ability to work | Age, education, past work, transferable skills |
The SSA uses the Medical Improvement Review Standard (MIRS): benefits can only be terminated if there has been medical improvement and that improvement is related to your ability to work. A cured infection with continued cirrhosis complications may not meet that bar.
If you're currently applying for SSDI based on hepatitis C, a cure during the application process adds complexity. The SSA will evaluate your condition as of your alleged onset date and across your claim period.
Key variables in this scenario:
The onset date — the date the SSA determines your disability began — shapes the entire benefit calculation, including how much back pay you may be owed.
Where you are in the SSDI process affects how a cure is weighed:
The SSA's rules on medical improvement, RFC assessment, and CDR timelines are public and consistent. What those rules produce for any individual claimant depends entirely on the specifics of their medical record — the fibrosis stage documented before and after treatment, current lab values, physician opinions, symptom history, and work background.
A hepatitis C cure is genuinely good news medically. Whether it changes your SSDI status depends on what the virus left behind — and how thoroughly that's reflected in your file.
